248 related articles for article (PubMed ID: 18192686)
1. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells.
Lehmann L; Jiang L; Wagner J
Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686
[TBL] [Abstract][Full Text] [Related]
2. Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in cultured MCF-7 cells.
Wagner J; Jiang L; Lehmann L
Adv Exp Med Biol; 2008; 617():625-32. PubMed ID: 18497090
[TBL] [Abstract][Full Text] [Related]
3. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
4. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
[TBL] [Abstract][Full Text] [Related]
5. Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage.
van Duursen MB; Sanderson JT; de Jong PC; Kraaij M; van den Berg M
Toxicol Sci; 2004 Oct; 81(2):316-24. PubMed ID: 15254334
[TBL] [Abstract][Full Text] [Related]
6. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
Ashburn SP; Han X; Liehr JG
Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
[TBL] [Abstract][Full Text] [Related]
7. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
Dawling S; Hachey DL; Roodi N; Parl FF
Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
[TBL] [Abstract][Full Text] [Related]
8. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
Garner CE; Burka LT; Etheridge AE; Matthews HB
Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
[TBL] [Abstract][Full Text] [Related]
9. Gene expression of 17beta-estradiol-metabolizing isozymes: comparison of normal human mammary gland to normal human liver and to cultured human breast adenocarcinoma cells.
Lehmann L; Wagner J
Adv Exp Med Biol; 2008; 617():617-24. PubMed ID: 18497089
[TBL] [Abstract][Full Text] [Related]
10. Nordihydroguaiaretic Acid as a Novel Substrate and Inhibitor of Catechol
Kim JH; Lee J; Jeong H; Bang MS; Jeong JH; Chang M
Molecules; 2021 Apr; 26(7):. PubMed ID: 33916785
[TBL] [Abstract][Full Text] [Related]
11. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney.
Zhu BT; Liehr JG
Toxicol Appl Pharmacol; 1994 Mar; 125(1):149-58. PubMed ID: 8128490
[TBL] [Abstract][Full Text] [Related]
12. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
Butterworth M; Lau SS; Monks TJ
Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
[TBL] [Abstract][Full Text] [Related]
13. 17 beta-Estradiol metabolism by hamster hepatic microsomes. Implications for the catechol-O-methyl transferase-mediated detoxication of catechol estrogens.
Butterworth M; Lau SS; Monks TJ
Drug Metab Dispos; 1996 May; 24(5):588-94. PubMed ID: 8723741
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.
Chang I; Liu J; Majid S; Saini S; Zaman MS; Yamamura S; Shahryari V; Chiyomaru T; Deng G; Dahiya R; Tanaka Y
Carcinogenesis; 2012 Feb; 33(2):420-6. PubMed ID: 22159223
[TBL] [Abstract][Full Text] [Related]
15. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase.
Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL
Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597
[TBL] [Abstract][Full Text] [Related]
16. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
17. Catechol metabolites of zeranol and 17β-estradiol: a comparative in vitro study on the induction of oxidative DNA damage and methylation by catechol-O-methyltransferase.
Fleck SC; Hildebrand AA; Pfeiffer E; Metzler M
Toxicol Lett; 2012 Apr; 210(1):9-14. PubMed ID: 22285433
[TBL] [Abstract][Full Text] [Related]
18. Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer.
Zhu BT
Int J Oncol; 2003 Mar; 22(3):499-508. PubMed ID: 12579301
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.
Goodman JE; Jensen LT; He P; Yager JD
Pharmacogenetics; 2002 Oct; 12(7):517-28. PubMed ID: 12360102
[TBL] [Abstract][Full Text] [Related]
20. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
